Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02479906 · ClinicalTrials.gov registry record · NA
A Safety & Efficacy Study With Deep Transcranial Magnetic Stimulation for the Treatment of Post-Traumatic Stress Disorder (PTSD)
A NA study, sponsored by Brainsway.
- Terminated
- Registry status
- NA
- Development phase
- 203
- Enrollment target
NCT02479906: Clinical Trial NA study, sponsored by Brainsway.
NCT02479906 is a NA study that was terminated before completion, run by Brainsway. The registered enrollment target is 203 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02479906, a NA study, was terminated before completion, sponsored by Brainsway.
- TERMINATED
- Registry status
- NA
- Development phase
- 203 participants
- Enrollment target
Study Summary
The purpose of the present study is to evaluate the safety and efficacy of Brainsway Deep TMS (DTMS) for the treatment of PTSD.
Primary Outcome
CAPS-5 Score measured by change from baseline.
Interventions
- DEVICE Sham Treatment
- DEVICE Deep TMS System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2016-11-17 |
| Est. Completion | 2020-03-31 |
| Phase | NA |
Why NCT02479906 stopped before completion
NCT02479906 is an interventional study that assigns participants to a tested intervention. The registered 203 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham Treatment is the first listed.
NCT02479906 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02479906 about?
NCT02479906 is a clinical study titled "A Safety & Efficacy Study With Deep Transcranial Magnetic Stimulation for the Treatment of Post-Traumatic Stress Disorder (PTSD)". The purpose of the present study is to evaluate the safety and efficacy of Brainsway Deep TMS (DTMS) for the treatment of PTSD.
What is the current status of trial NCT02479906?
This trial is currently terminated. It is a NA study. The enrollment target is 203 participants. The study started on 2016-11-17. Estimated completion is 2020-03-31.
What interventions are being tested in trial NCT02479906?
The interventions under investigation include: Sham Treatment (DEVICE), Deep TMS System (DEVICE).
Who is sponsoring clinical trial NCT02479906?
This trial is sponsored by Brainsway, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02479906's enrollment target sits among peer trials
203 504th of 2000 higher than 1,496 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05652686 · 203 participants · Phase 1
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- NCT06063122 · 203 participants · NA
Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
- NCT07031245 · 203 participants · NA
Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI